MediPharm Labs and Valens GroWorks are the two leaders in Canadian cannabis extraction. MediPharm MIGHT be the best value for investors at present.
Cannabis News
Rapid Dose Therapeutics Signs QuickStrip(TM) Distribution Agreement, Receives US$2.1 Million Purchase Order
Rapid Dose signs 12-month export agreement with Eastern European countries, receives $2.1 million purchase order
The New Hemp Energy Drink Soon Available In More Than 500 Quebec Stores
Tetra Bio-Pharma's Hemp Energy Drink to be distributed in more than 500 Quebec grocery/convenience stores
Canada’s Fastest-Growing Cannabis Leader
Alberta leads Canada in opening up a legal cannabis industry. The province is already cashing in. Investors can as well.
Canopy Rivers Reports Fourth Quarter and Fiscal Year 2019 Financials and Provides Corporate Update
Canopy Rivers reports fourth quarter and fiscal year 2019 financial results
TILT Holdings Signs Term Sheet for U.S. $125 Million Convertible Note Financing
Convertible senior secured notes will provide TILT with up to US$125 million in funding
MediPharm Labs Provides Update, Increases Weekly Production of Active Cannabinoids to 75 Million Milligrams
MediPharm updates investors on operations and announces successful ramp-up of extraction capacity
Valens Reports Record $8.8 Million in Revenue, Adjusted EBITDA of $2.0 Million in the Second Quarter of Fiscal 2019
Valens GroWorks reports record Q2 revenues of CAD$8.8 million, gross profit of $5.1 million
Mother Thanks Medicinal Cannabis: ‘I have my life back’
After 10 years of conventional medications left her bed-ridden, medicinal cannabis fully restored this mother's life
Organigram Reports Third Quarter Fiscal 2019 Results
Organigram reports Q3 revenues of CAD$24.8 million and a Q3 net loss of CAD$10.2 million
